10 surgical robotics firms to comply with in 2024

Take heed to this text

The da Vinci SP surgical robotics system. | Supply: Intuitive Surgical

The surgical robotics house noticed a serious shakeup final yr. “Robotics is difficult. Robotics in healthcare is difficult.”

Hani Abouhalka, Johnson & Johnson’s firm group chair for Robotics & Digital, mentioned these phrases at DeviceTalks West, which was co-located with RoboBusiness in California in October. 

It just about sums up the state of affairs for medtech firms giant and small that sought to compete in opposition to Intuitive Surgical within the soft-tissue surgical robotics house. Regardless of the elevated competitors, Intuitive stays the undisputed chief. It’s even transferring ahead on a next-gen da Vinci robotic.

For its half, Johnson & Johnson is sticking with plans to develop its Ottava surgical robotic. J&J now plans to submit Ottava for FDA investigational system exemption (IDE) within the second half of 2024 with the intention to begin scientific trials.

Surgical robotics builders minimize staffers

Though it’s sticking with robotic surgical procedure, J&J laid off staff within the subject in 2023. Different firms, together with Vicarious Surgical, have additionally minimize jobs.

In the meantime, Titan Medical has principally wound down. And Siemens Healthineers mentioned final yr that it could discontinue using its Corindus surgical robots for cardiology procedures.

Listed here are 10 surgical robotics firms that proceed to draw consideration from our editors and viewers:

And right here is extra concerning the 10 firms:

Intuitive Surgical: Reaping the advantages of being a pioneer

Corporations of all sizes are attempting to compete in opposition to Intuitive Surgical within the soft-tissue surgical robotics house, nevertheless it stays the undisputed chief.

Since its founding within the Nineties, the Sunnyvale, Calif.–based mostly firm has positioned greater than 8,000 multiport and single-port methods across the globe and racked up greater than 14 million procedures, together with roughly 2.3 million simply final yr.

“I do see us because the chief, because the pioneer,” mentioned Dave Rosa, president of Intuitive Surgical, throughout DeviceTalks West in Santa Clara, Calif.

Promoted to the place of president in Could 2023, the 27-year firm veteran supplied his recommendation on perseverance to medical system builders: “Opponents and the rising subject, it’s so thrilling [because] that validates the … blood, sweat and tears that our crew has put in to forge this subject and present that there’s profit with robotics. We are able to do issues higher, not solely bringing extra minimally invasive surgical procedure to the world, however [also by] doing it with higher choices than laparoscopy may. … And now we now have large and small firms coming in and saying, ‘We are able to make a distinction too.’”

In January, Intuitive introduced that it has submitted for FDA 510(okay) clearance of its next-generation da Vinci 5 multiport surgical robotic. Firm officers mentioned they hope for a launch this yr.

The da Vinci 5 will be a part of Intuitive’s present robotic surgical system portfolio, which incorporates the multiport X and Xi methods and the single-port SP. The corporate additionally gives Ion, a robotic-assisted platform for minimally invasive biopsy within the lung.

In a separate podcast, Rosa recognized two technological alternatives that he thinks are going to advance surgical robotics and minimally invasive surgical procedure in a serious method: improved visualization for surgeons and focal remedy. Rosa mentioned these applied sciences make Intuitive a minimally invasive care firm.

Intuitive continues to dominate surgical robotics. Pictured is the da Vinci Xi system. | Supply: Intuitive Surgical

Further Intuitive protection:

Asensus Surgical: Constructing a next-gen system that may final

Seven years after its Senhance robotic surgical procedure system gained FDA clearance, Asensus Surgical has unveiled its next-gen Luna platform. The corporate struck a cope with Flex to fabricate Luna and is looking for an FDA clearance in 2025.

Throughout DeviceTalks West 2023, Dustin Vaughan, vp of analysis and growth at Asensus, described Luna’s enhancements. They included a 30% smaller footprint; absolutely articulated, reusable TrueWrist 5 mm devices; and a singular surgeon console and ergonomic advantages.

Asensus Surgical lately confirmed off Luna to surgeons. Right here’s a video:

The years of growth behind Luna additionally included the creation of an instrument drive system, a desktop take a look at system to allow extra instrument innovation.

In accordance with Vaughan, one of many biggest challenges to beat when designing the system was to make sure that the platform may assist the layering of latest, revolutionary instruments and software program not only for the following yr, but additionally for the following decade.

“We’ve seen how difficult this house is to get the capital gear,” he mentioned. “As passionate as I’m personally about robotics, it doesn’t change the truth that this would be the similar system for a lot of, a few years. … You’ve acquired to get this proper, since you’re going to take a look at it and develop on it for a really very long time.”

CMR Surgical: A British Invasion for surgical robotics?

Over the previous yr, the Cambridge, U.Okay.–based mostly maker of the Versius surgical robotic system has launched a number of initiatives to set itself up for achievement:

“I believe it has been an awesome yr of making an attempt to do what is sweet for the corporate,” Bose mentioned in a current interview with MassDevice. Bose, co-founder and Chief Medical Officer Mark Slack, and co-founder and Chief Expertise Officer Luke Hares will converse at DeviceTalks Boston.

In 2023, CMR Surgical’s put in base grew 50% to 160, and annual surgical process numbers grew 60% to 17,000. Bose touted the benefits of Versius, together with a smaller cellular design that enables it to be wheeled round well being services, an open console that allows surgeons to information their working room workers higher, and a extra reasonably priced worth level.

This yr, CMR Surgical plans to roll out enhancements in imaginative and prescient know-how, instrumentation, and digital merchandise to additional strengthen Versius’ worth.

CMR Surgical’s Versius surgical robotics system in motion. | Supply: CMR Surgical

Medtronic: Hugo continues to roll out internationally

The world’s largest medical system firm continues to develop using its Hugo soft-tissue surgical robotics system outdoors the U.S. In 2023, Medtronic gained the FDA’s permission to start out its pivotal trial for Hugo robotic-assisted hernia procedures. It additionally continued its Increase URO trial for prostatectomies.

Hugo combines wristed devices, 3D visualization, and Medtronic’s cloud-based surgical video seize and administration answer, Contact Surgical procedure Enterprise. The concept is to supply a multi-quadrant platform for a variety of sentimental tissue procedures.

“We count on Hugo, geared up with superior digital capabilities, to be a significant development driver for us within the years forward,” mentioned CEO Geoff Martha throughout a November 2023 earnings name.

“We consider surgeon desire with our open console and modular design, our main place in minimally invasive surgical procedure and instrumentation, our related digital ecosystem and data-enabled insights — together with our world-class surgical coaching program and partnerships — will meaningfully advance the low penetration of robotic surgical procedure world wide,” he mentioned.

Nonetheless, Medtronic has confronted questions over whether or not Hugo will be capable of compete in opposition to Intuitive’s da Vinci methods domestically. BTIG analysts checked out the Hugo system throughout a convention in Montreal in March 2023, and remarked in a follow-up notice that they didn’t suppose it was completely different sufficient from present choices.

“An enormous variety of surgeons need selection of their robotics system, and whereas we’re not discounting this, we expect [Medtronic’s] entrance into the U.S. can be measured,” mentioned BTIG’s Ryan Zimmerman, Sam Durno and Iseult McMahon.

In the meantime, Truist analysts famous in October 2023 that Medtronic’s Mazor is the primary to market with a bone-cutting utility, doubtlessly a primary step towards extra subtle tissue-removing backbone procedures.

Mentioned Richard Newitter, Samuel Brodovsky, Benjamin Goldstein, and Lin Zhang at Truist: “That is the primary bone-cutting utility available on the market and an necessary indication growth as robotic applied sciences transfer to broader applicability in backbone procedures past pedicle screw placement and dealing in the direction of extra subtle maneuvering deeper inside the backbone.”

Medtronic’s Hugo robotic surgical procedure system. | Supply: Medtronic

Johnson & Johnson: Shifting ahead on Ottava

For years, Johnson & Johnson officers have solely mentioned “keep tuned” when requested about plans for the corporate’s Ottava soft-tissue surgical robotics system, its bid to compete with Intuitive.

In November 2023, J&J lastly broke its silence, saying that it plans to submit Ottava for FDA investigational system exemption (IDE) within the second half of 2024 to provoke scientific trials.

“We’re nicely beneath strategy to be prepared for the scientific research,” Abouhalka mentioned in December, including that the corporate plans to proceed innovating in robotics “for what’s subsequent in surgical procedure.”

Ottava incorporates 4 robotic arms right into a standard-size surgical desk, down from the six arms proven years in the past. Its unified structure permits for an invisible design, J&J mentioned. The robotic arms can be found when wanted and stowed beneath the surgical desk when not.

The system additionally gives a “twin movement” function, with the unified motion of the desk and robotic arms. J&J designed it this strategy to permit surgical groups to deal with necessary scientific wants throughout surgical procedure. That would embrace repositioning a affected person with out interrupting the process.

“With Ottava, we intend to drive simplicity and new experiences by means of our distinctive structure,” Rocco De Bernardis, world president of Ottava, instructed MassDevice.

In the meantime, the corporate’s Monarch platform and Monarch bronchoscope lately obtained regulatory approval in China, the primary robot-assisted know-how from Johnson & Johnson MedTech to get accepted there.

Within the ortho-robotic surgical procedure house, Velys system procedures are within the 1000’s. J&J’s DePuy Synthes orthopedic system enterprise boasted that Velys is a first-of-its-kind, table-mounted ortho surgical procedure robotic with an environment friendly design that integrates into any working room.

Be taught from Agility Robotics, Amazon, Disney, Teradyne and plenty of extra.

Stryker: On observe for brand spanking new Mako functions

The world’s largest orthopedic system firm mentioned its Mako surgical robotic for orthopedic procedures continues to drive development.

Throughout Stryker’s This autumn earnings name close to the tip of January, firm officers mentioned the system had a document variety of installations globally in the course of the quarter. Within the U.S., Stryker mentioned 60% of its knee alternative procedures and 34% of its hip replacements have been carried out utilizing Mako that yr.

Mako for backbone surgical procedure is coming within the third quarter of 2024, with Mako shoulder coming close to the tip of the yr.

In the course of 2023, Stryker introduced that it deliberate to spice up demand for Mako-supported surgical procedures much more with a direct-to-patient advertising and marketing marketing campaign within the U.S. known as “Scan. Plan. Mako Can.”

Stryker officers are additionally excited concerning the potential to make use of AI to raised analyze well being knowledge to enhance surgical robotics outcomes in orthopedics.

The aim of the Mako surgical robotic arm is to offer extra predictable outcomes. | Supply: Stryker

Moon Surgical: A surgical robotics assistant

Based mostly in Paris and San Carlos, Calif., Moon Surgical has taken a unique strategy to robotic surgical procedure. Its Maestro system is a robotic surgical assistant, as a substitute of performing surgical procedures beneath a surgeon’s management. The firm‘s acknowledged aim is to offer an accessible, enhanced model of conventional laparoscopy with extra precision and management.

The small, adaptable system can combine into present scientific workflows, in response to Moon Surgical. It options capabilities that bolster working room effectivity and permit for various labor fashions.

Maestro’s additional set of arms gives surgeons management of two further devices. It offers optimum imaginative and prescient and entry to tissue all through the process, Moon Surgical says.

Moon Surgical in October 2023 noticed its first U.S. scientific instances with an preliminary model of Maestro in Jacksonville, Fla. The following month, it introduced profitable surgical procedures in France.

The corporate has secured FDA 510(okay) clearance and a CE mark for Maestro.

Further Moon Surgical protection:

Moon Surgical’s Maestro surgical robotic. | Supply: Moon Surgical

Stereotaxis: A partnership with Abbott

Stereotaxis offers surgical robotics that includes magnets for minimally invasive endovascular intervention. Its merchandise embrace the Genesis RMN system, Vdrive robotic navigation system, and Niobe robotic magnetic navigation system.

The St. Louis, Mo.-based firm’s know-how has handled greater than 100,000 sufferers worldwide

Latest wins embrace the first sufferers efficiently handled utilizing the corporate’s Magnetic Interventional Ablation Catheter (MAGiC). MAGiC is a robotically navigated magnetic ablation catheter designed to carry out minimally invasive cardiac ablation procedures. The primary procedures came about at Vilnius College Hospital Santaros Klinikos in Lithuania.

Final yr, Stereotaxis cast a partnership with Abbott to combine the Abbott EnSite X EP system — a 3D coronary heart mapping system — with Stereotaxis’ robotic magnetic navigation methods. Stereotaxis in October 2023 introduced the primary procedures performed beneath the partnership.

The complete Stereotaxis lab with the Genesis RMN system. | Supply: Stereotaxis

Distalmotion: Looking for continued industrial growth of Dexter

Switzerland-based Distalmotion is the developer of the Dexter surgical robotics system. Dexter simply integrates into scientific follow, claimed the corporate. It requires no further infrastructure, suits into each scientific setting and options mobility for sharing throughout departments. Establishments can then scale robotics packages throughout surgical disciplines, enhancing the usual of care, mentioned Distalmotion.

At the moment in day-to-day scientific use in Europe, Dexter treats sufferers throughout advanced and high-volume process sorts. That features basic surgical procedure, gynecology, and urology. Final yr, Distalmotion raised $150 million to push towards FDA approval, plus the continued acceleration of scientific expertise in Europe. Zimmer Biomet and Stryker veteran Greg Roche joined as CEO close to the tip of the yr.

Distalmotion lately partnered with Proximie, which develops an working room working system that gives hospitals and surgical facilities entry to preoperative knowledge that may assist inform affected person care — plus real-time collaborative instruments to document, practice, and ship care.

The Dexter surgical robotic platform. | Supply: Distalmotion

Noah Medical: 500-case mark for Galaxy

Noah Medical lately introduced the five hundredth use of its Galaxy surgical robotic system for robotic-assisted bronchoscopy within the U.S.

The San Carlos, Calif.–based mostly firm designed Galaxy and its equipment to offer bronchoscopic visualization and entry. These capabilities present diagnostic and therapeutic procedures in affected person airways.

The system options superior imaging applied sciences that present real-time location updates for doubtlessly cancerous lesions. Noah Medical mentioned it designed the know-how to enhance tool-in-lesion and diagnostic yield.

Galaxy makes use of proprietary built-in tomosynthesis known as TiLT Expertise. It allows augmented fluoroscopy with a disposable single-use bronchoscope with always-on imaginative and prescient, and a small, compact footprint that enables for simple integration into most bronchoscopy suites.

The corporate introduced in April 2023 that it had raised $150 million in a Collection B spherical.

Noah Medical CEO Jian Zhang in December 2023 shared his surgical robotics business outlook with MassDevice sibling website Medical Design & Outsourcing.

Different surgical robotics firms we’re maintaining a tally of

• Procept BioRobotics is the developer of the AquaBeam robotic system, which it describes as an image-guided, heat-free robotic remedy for the therapy of decrease urinary tract signs attributable to benign prostatic hyperplasia. In September 2023, the San Jose, Calif.-based firm introduced an FDA IDE for its Aquablation remedy. Intuitive co-founder Dr. Fred Moll has been the board chair since 2021.
• Vicarious Surgical’s know-how combines proprietary human-like surgical robots with 3D visualization to move surgeons contained in the affected person to carry out minimally invasive surgical procedure. The Waltham, Mass.–based mostly firm’s know-how has generated plenty of buzz prior to now, however final yr noticed the corporate push again timelines for its Model 1.0 system and have interaction in layoffs. The corporate lately introduced on Olympus and Flex veteran ​​Randy Clark as president, reporting to co-founder and CEO Adam Sachs.
• Momentus Surgical, previously Memic Progressive Surgical procedure, developed the Anovo system that featured miniature humanoid-shaped arms. CTech reported that there have been layoffs on the Tel, Aviv, Israel–based mostly firm final yr.
• Zimmer Biomet’s Rosa surgical robotics methods for mind, hip and whole knee procedures are a part of the corporate’s general ZBEdge digital and robotic know-how suite. Liane Teplitsky, robotics, know-how and knowledge president of the firm, supplied knowledge integration recommendation and recognized alternatives past orthopedics in an interview with Medical Design & Outsourcing final yr.
• Smith+Nephew gives its Cori surgical system for knee and hip surgical procedures. It features a 3D intraoperative imaging system and a complicated robotic sculpting software.
• Monteris Medical is a privately held firm based mostly in Minnetonka, Minn., that develops magnetic resonance-guided ablation methods to carry out minimally invasive, robotically managed mind surgical procedure.
• Ronovo Surgical in Shanghai unveiled its Carina robotic platform a yr in the past. Carina, a modular system constructed on proprietary know-how, allows configurable robotic help for laparoscopic surgical procedures throughout a number of specialties.
• EndoQuest Robotics — a Houston-based endoluminal surgical robotic know-how developer — introduced in December 2023 that it closed a C-1 most popular financing spherical value $42 million in proceeds. The corporate designed its platform to deal with unmet wants in gastrointestinal and different endoluminal surgical procedures. It lately partnered with Omnivision on visualization for robotic surgical procedure.
• MMI (Medical Microinstruments) is the developer of the Symani surgical robotics system for microsurgery and supermicrosurgery. The Pisa, Italy–based mostly firm is led by Mark Toland, the previous CEO of Corindus Vascular Robotics. The system has a CE mark in Europe. In October, MMI introduced two distribution agreements overlaying practically a dozen international locations within the Asia Pacific area.
• Levita Magnetics in December 2023 introduced the worldwide launch of its MARS (magnetic-assisted robotic surgical procedure) system with its placement at Hospital Luis Tisne in Santiago, Chile. The MARS system was additionally lately used for its first U.S. industrial instances on the Cleveland Clinic. Mountain View, Calif.-based Levita designed the MARS platform for high-volume stomach surgical procedures resembling laparoscopic bariatric surgical procedures, cholecystectomies, and prostate and colorectal procedures.
• Virtuoso Surgical has an endoscopic surgical system that it mentioned delivers two robotically managed, needle-sized manipulators that work from the tip of a inflexible endoscope lower than half the diameter of a U.S. dime. The Nashville, Tenn.-based firm introduced in November 2023 that it had acquired a $1.8 million NIH Small Enterprise Innovation Analysis (SBIR) grant.
• Quantum Surgical introduced in September 2023 that the Nationwide Medical Merchandise Administration (NMPA) approved its Epione surgical robotic in China. Information of the regulatory nod got here simply weeks after Montpellier, France–based mostly Quantum secured a CE mark growth for Epione to deal with lung tumors. The percutaneous ablation system makes use of a robotic arm, a navigation system, and a digicam. It inserts a needle by means of the pores and skin to the tumor and destroys it.
• Medicaroid is a Japan-based surgical robotics firm that has developed the Hinotori system, which acquired regulatory approval in Japan in 2020 and launched the identical yr. The system final yr acquired regulatory approval in Singapore.
• Triton Medical Robotics (Neptune Medical) is taking the Dynamic Rigidization know-how developed at Neptune and utilizing it to develop a completely versatile medical robotic to allow docs to achieve deep into human anatomy. In late 2023, Neptune Medical introduced that it had appointed Moll as its board chair.

Editor’s notes: Affiliate Editor Sean Whooley contributed to this text, which was syndicated from MassDevice, a sibling website to The Robotic Report.

There can be loads of surgical robotics shows at WTWH Media’s DeviceTalks Boston occasion, which can be co-located with the Robotics Summit & Expo. Registration is now open.